Results 81 to 90 of about 28,958 (244)
Percutaneous Sclerotherapy for Giant Hepatic Haemangiomas: A New Paradigm in Australia
ANZ Journal of Surgery, EarlyView.
Warren Clements +3 more
wiley +1 more source
Journal of Cardiovascular Electrophysiology, EarlyView.This study compared STDE‐guided versus LVZ‐guided ablation beyond PVI in 107 persistent AF patients. At 24 months, the AF‐free survival rate was significantly higher in the STDE group (76.3% vs. 58.4%, p=0.027). STDE ablation independently reduced recurrence risk (HR: 0.29, p=0.004), providing superior clinical efficacy over LVZ ablation.
Yutaro Kaneko +6 more
wiley +1 more source
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Health and Quality of Life Outcomes, 2017 Background Novel oral anticoagulants (NOAC) such as dabigatran, when compared to warfarin, have been shown to potentially reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) together with lower healthcare resource ...
Shannon L. Reynolds +9 more
doaj +1 more source
Dabigatran-induced esophagitis
Cleveland Clinic Journal of Medicine, 2019 The tablets contain tartaric acid, and if they get stuck in the esophagus, the acid leaching out can damage the mucosa.
openaire +2 more sources
Journal of Cardiovascular Electrophysiology, EarlyView.In anticoagulated atrial fibrillation, residual ischemic stroke risk persists despite guideline‐directed therapy. In this single‐center cohort, an enlarged index outpatient left atrial diameter independently predicted stroke and improved risk stratification when added to CHA2DS2‐VA (CHA2DS2‐VALa), supporting a simple, clinically implementable ...
Sefa Erdi Ömür +7 more
wiley +1 more source
Dabigatran and apolipoprotein B [PDF]
Heart, 2015 Dabigatran is the first of a series of new direct acting oral anticoagulants that was clinically introduced for the prevention of ischaemic stroke in patients with atrial fibrillation (AF). In the randomized evaluation of long-term anticoagulation therapy (RE-LY) study, dabigatran was shown to be superior or non-inferior to warfarin in preventing ...
openaire +2 more sources
Journal of Cardiovascular Electrophysiology, EarlyView.ABSTRACT Background Amiodarone is frequently co‐prescribed with direct oral anticoagulants (DOACs) in atrial fibrillation (AF), but its impact on early bleeding risk after DOAC initiation in older adults remains uncertain. We evaluated short‐term safety outcomes associated with concomitant amiodarone use at the time of DOAC initiation.
Isadora D. Guarino, Saman Nazarian
wiley +1 more source
Journal of Gastroenterology and Hepatology, EarlyView.ABSTRACT Background and Aims Colorectal endoscopic mucosal resection (EMR) and hot snare polypectomy (HSP) are high‐bleeding‐risk endoscopic procedures, and most clinical guidelines recommend stopping direct oral anticoagulants (DOACs) temporarily or switching to heparin‐bridging therapy (HBT). However, existing evidence is largely derived from cohorts
Yutaka Okagawa +16 more
wiley +1 more source
Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
Pharmaceuticals, 2012 Dabigatran is an oral thrombin inhibitor which has been approved in several countries as an alternative to vitamin-K-antagonists for the prevention of stroke or embolism in atrial fibrillation patients.
Josef Finsterer, Claudia Stöllberger
doaj +1 more source
Journal of the American Geriatrics Society, EarlyView.ABSTRACT Background Direct oral anticoagulants (DOACs) are prescribed using fixed dosing regimens, despite limited evidence on their pharmacokinetic behavior in nursing home residents. Participants and Setting One hundred nursing home residents are receiving apixaban, rivaroxaban, dabigatran, or edoxaban in multiple long‐term care facilities in the ...
Irme S. Franssen +11 more
wiley +1 more source